SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
321[4904] <b>Mechanism of Arsenic Trioxide-Induced Apoptosis on Multiple MyelIan@SI-11/29/2004
320[4731] <b>Prolonged Administration of Arsenic Trioxide (Trisenox®) foIan@SI-11/29/2004
319[4466] <b>Arsenic Trioxide (ATO) Downregulates the Expression of the AML1/Ian@SI-11/29/2004
318There are numerous Publication Only "sessions". Some follow. [I'mIan@SI-11/29/2004
317Monday, December 6, 2004, 05:30 PM <b>[3479] Arsenic Trioxide and AscorbicIan@SI-11/29/2004
316Monday, December 6, 2004, 05:30 PM <b>[3397] MEK1 Inhibition and Arsenic TIan@SI-11/29/2004
315Monday, December 6, 2004, 05:30 PM <b>[3128] Threshold of Credibility: NewIan@SI-11/29/2004
314Monday, December 6, 2004, 02:00 PM <b>[393] Use of All-Transretinoic Acid Ian@SI-11/29/2004
313Sunday, December 5, 2004, 06:00 PM <b>[2457] Comparisson of Molecular MechIan@SI-11/29/2004
312Sunday, December 5, 2004, 06:00 PM <b>[2398] A Phase I/II Multicenter, SafIan@SI-11/29/2004
311Note: This abstract contains graphs which can't be posted here... ++++++++Ian@SI-11/29/2004
310<b>Sunday, December 5, 2004, 06:00 PM [2098] Glutathione-Depletion PotentlIan@SI-11/29/2004
309<b>Sunday, December 5, 2004, 06:00 PM [1803] Organic Arsenic Lipid DerivatIan@SI-11/29/2004
308<b>Saturday, December 4, 2004, 06:00 PM [1433] Trisenox® (arsenic triIan@SI-11/29/2004
307<b>Saturday, December 4, 2004, 06:00 PM [1067] Single Knock-In PML-RARa ExIan@SI-11/29/2004
306<b>Saturday, December 4, 2004, 06:00 PM [886] All-Trans-Retinoic Acid (ATRIan@SI-11/29/2004
305<b>Monday, December 6, 2004, 05:30 PM [3402] Investigations on the MechaniIan@SI-11/29/2004
304<b>Sunday, December 5, 2004, 06:00 PM [2489] Preliminary Phase II Study ReIan@SI-11/29/2004
303The next few posts will contain ASH abstracts. If not interested, skip any messIan@SI-11/29/2004
302Arsenic Trioxide and Pixantrone Highlighted in 42 Abstracts and Presentations atIcebrg-11/23/2004
301Fed scrutiny over Cell Therapeutics' marketing tactics >>I really don&Icebrg-11/20/2004
300I really don't like these Friday Evening PRs... CTI in Discussion With U.S.Ian@SI-11/19/2004
299<i> $17 target does represent a nice annual return if it happens</i>tom pope-11/15/2004
298Erik, Nice site, thanks for the URL. All the same, a $17 target does representIan@SI-11/15/2004
297They have been coming down over time from 53. Go to stockpricetargets.com and enIcebrg-11/15/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News